|
SourceOne Stock Info Your one source site for
stock research |
||||||||||||
Investor RelationsWhat’s the buzz— message boards
|
Amgen Inc.
AMGN Amgen Inc. is a global biotechnology company that
discovers, researches, develops, manufactures, and markets human therapeutics
based on advances in cellular and molecular biology. The company operates in
one business unit: human therapeutics. Amgen markets human therapeutic
products in the areas of nephrology, supportive cancer care and inflammatory
disease. Its principal products include EPOGEN (Epoetin alfa), Aranesp
(darbepoetin alfa), Neulasta (pegfilgrastim), NEUPOGEN (Filgrastim) and
ENBREL (etanercept), which is marketed under a co-promotion agreement with
Wyeth in the Stock Quotes and Other InformationSearch
for Stocks: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Alphabetical
Listings by Company Name S&P
100 S&P
500 S&P
400 Dow Jones
Industrials Dow Jones Transportation Dow Jones
Utilities Dow Jones Composite Nasdaq 100 Morgan Stanley Hi-Tech 35 |
|
||||||||||